PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--Stentys, which develops innovative stents to treat Acute Myocardial Infarction (AMI), announced today the enrollment of the final patient in the APPOSITION II clinical study—a randomized trial comparing the Stentys self-expanding stent with a conventional balloon-expandable stent in patients with AMI. The study results will be announced in September.
